Nicholas Simon - Net Worth and Insider Trading

Nicholas Simon Net Worth

The estimated net worth of Nicholas Simon is at least $2 Million dollars as of 2024-05-31. Nicholas Simon is the Director, 10% Owner of Gritstone Bio Inc and owns about 2,567,445 shares of Gritstone Bio Inc (GRTS) stock worth over $2 Million. Details can be seen in Nicholas Simon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nicholas Simon has not made any transactions after 2018-09-28 and currently still holds the listed stock(s).

Transaction Summary of Nicholas Simon

Nicholas Simon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicholas Simon owns 12 companies in total, including Gritstone Bio Inc (GRTS) , Sientra Inc (SIENQ) , and Entasis Therapeutics Holdings Inc (ETTX) among others .

Click here to see the complete history of Nicholas Simon’s form 4 insider trades.

Insider Ownership Summary of Nicholas Simon

Ticker	Comapny	Transaction Date	Type of Owner
GRTS	Gritstone Bio Inc	2018-09-28	director
SIENQ	Sientra Inc	2017-06-22	director & 10 percent owner
ETTX	Entasis Therapeutics Holdings Inc	2018-09-25	10 percent owner
		2018-07-02	10 percent owner
		2017-10-11	10 percent owner
		2016-02-08	10 percent owner
		2015-06-15	10 percent owner
		2013-09-25	10 percent owner
		2013-10-25	10 percent owner
		2012-08-02	other: Managing dir. of GP
		2012-06-04	director
		2011-09-16	10 percent owner

Nicholas Simon Latest Holdings Summary

Nicholas Simon currently owns a total of 1 stock. Nicholas Simon owns 2,567,445 shares of Gritstone Bio Inc (GRTS) as of September 28, 2018, with a value of $2 Million.

Latest Holdings of Nicholas Simon

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
GRTS	Gritstone Bio Inc	2018-09-28	2,567,445	0.76	1,962,812

Holding Weightings of Nicholas Simon

Nicholas Simon Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicholas Simon has made a total of 0 transactions in Gritstone Bio Inc (GRTS) over the past 5 years. The most-recent trade in Gritstone Bio Inc is the acquisition of 333,333 shares on September 28, 2018, which cost Nicholas Simon around $5 Million.

Insider Trading History of Nicholas Simon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicholas Simon Trading Performance

GuruFocus tracks the stock performance after each of Nicholas Simon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicholas Simon is 9.62%. GuruFocus also compares Nicholas Simon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicholas Simon within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nicholas Simon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nicholas Simon

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	18.19
Relative Return to S&P 500(%)	26.95

Nicholas Simon Ownership Network

Ownership Network List of Nicholas Simon

No Data

Ownership Network Relation of Nicholas Simon

Nicholas Simon Owned Company Details

What does Gritstone Bio Inc do?

Who are the key executives at Gritstone Bio Inc?

Nicholas Simon is the director of Gritstone Bio Inc. Other key executives at Gritstone Bio Inc include director & President and CEO Andrew R Allen , See Remarks Matthew Hawryluk , and See Remarks Karin Jooss .

Gritstone Bio Inc (GRTS) Insider Trades Summary

Over the past 18 months, Nicholas Simon made no insider transaction in Gritstone Bio Inc (GRTS). Other recent insider transactions involving Gritstone Bio Inc (GRTS) include a net sale of 1,749 shares made by Vassiliki Economides , a net sale of 24,263 shares made by Andrew R Allen , and a net sale of 13,749 shares made by Erin Jones .

In summary, during the past 3 months, insiders sold 74,769 shares of Gritstone Bio Inc (GRTS) in total and bought 0 shares, with a net sale of 74,769 shares. During the past 18 months, 74,769 shares of Gritstone Bio Inc (GRTS) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 62,769 shares.

Gritstone Bio Inc (GRTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Gritstone Bio Inc Insider Transactions

No Available Data

What does Sientra Inc do?

Who are the key executives at Sientra Inc?

Nicholas Simon is the director & 10 percent owner of Sientra Inc. Other key executives at Sientra Inc include director & President and CEO Ronald Menezes , General Counsel and VP Oliver Christian Bennett , and Chief Financial Officer Andrew C Schmidt .

Sientra Inc (SIENQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sientra Inc (SIENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sientra Inc (SIENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sientra Inc (SIENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sientra Inc Insider Transactions

No Available Data

What does Entasis Therapeutics Holdings Inc do?

Who are the key executives at Entasis Therapeutics Holdings Inc?

Nicholas Simon is the 10 percent owner of Entasis Therapeutics Holdings Inc. Other key executives at Entasis Therapeutics Holdings Inc include 10 percent owner Theravance Inc , VP & Principal Fin & Acct Off Kristie Ann Wagner , and General Counsel Elizabeth M Keiley .

Entasis Therapeutics Holdings Inc (ETTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Entasis Therapeutics Holdings Inc (ETTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entasis Therapeutics Holdings Inc (ETTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Entasis Therapeutics Holdings Inc (ETTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entasis Therapeutics Holdings Inc Insider Transactions

No Available Data

What does Forty Seven Inc do?

Who are the key executives at Forty Seven Inc?

Nicholas Simon is the 10 percent owner of Forty Seven Inc. Other key executives at Forty Seven Inc include Chief Financial Officer Ann D Rhoads , 10 percent owner Lightspeed General Partner X, L.p. , and 10 percent owner Lightspeed Ultimate General Partner X, Ltd. .

Forty Seven Inc (FTSV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Forty Seven Inc (FTSV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forty Seven Inc (FTSV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Forty Seven Inc (FTSV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Forty Seven Inc Insider Transactions

No Available Data

What does Venus Concept Inc do?

Who are the key executives at Venus Concept Inc?

Nicholas Simon is the 10 percent owner of Venus Concept Inc. Other key executives at Venus Concept Inc include President Global Sales Ross Portaro , 10 percent owner Michael Willingham Masters , and director & Chief Executive Officer Silva Rajiv De .

Venus Concept Inc (VERO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Venus Concept Inc (VERO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Venus Concept Inc (VERO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Venus Concept Inc (VERO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Venus Concept Inc Insider Transactions

No Available Data

What does TetraLogic Pharmaceuticals Corp do?

Who are the key executives at TetraLogic Pharmaceuticals Corp?

Nicholas Simon is the 10 percent owner of TetraLogic Pharmaceuticals Corp. Other key executives at TetraLogic Pharmaceuticals Corp include other: See Remarks Hudson Bay Capital Management Lp , other: See Remarks Lazard Asset Management Llc , and other: See Remarks Nomura Holdings Inc .

TetraLogic Pharmaceuticals Corp (TLOG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TetraLogic Pharmaceuticals Corp (TLOG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TetraLogic Pharmaceuticals Corp (TLOG)'s detailed insider trading history can be found in Insider Trading Tracker table.

TetraLogic Pharmaceuticals Corp Insider Transactions

No Available Data

What does Oxford Immunotec Global PLC do?

Who are the key executives at Oxford Immunotec Global PLC?

Nicholas Simon is the 10 percent owner of Oxford Immunotec Global PLC. Other key executives at Oxford Immunotec Global PLC include director & Chief Executive Officer Peter Wrighton-smith , Chief Financial Officer Mclaughlin Matthew T E , and Chief Operating Officer Stefan C Linn .

Oxford Immunotec Global PLC (OXFD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oxford Immunotec Global PLC (OXFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oxford Immunotec Global PLC (OXFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oxford Immunotec Global PLC (OXFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oxford Immunotec Global PLC Insider Transactions

No Available Data

What does IVERIC bio Inc do?

Who are the key executives at IVERIC bio Inc?

Nicholas Simon is the 10 percent owner of IVERIC bio Inc. Other key executives at IVERIC bio Inc include SVP & COO Keith Westby , SVP & CFO and Treasurer David Francis Carroll , and Senior Vice President & CCO Christopher Paul Simms .

IVERIC bio Inc (ISEE) Insider Trades Summary

Over the past 18 months, Nicholas Simon made no insider transaction in IVERIC bio Inc (ISEE). Other recent insider transactions involving IVERIC bio Inc (ISEE) include a net sale of 233,874 shares made by Keith Westby , a net sale of 128,049 shares made by David Francis Carroll , and a net sale of 19,457 shares made by Glenn Sblendorio .

In summary, during the past 3 months, insiders sold 0 shares of IVERIC bio Inc (ISEE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 381,380 shares of IVERIC bio Inc (ISEE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 381,380 shares.

IVERIC bio Inc (ISEE)'s detailed insider trading history can be found in Insider Trading Tracker table.

IVERIC bio Inc Insider Transactions

No Available Data

What does Aerie Pharmaceuticals Inc do?

Who are the key executives at Aerie Pharmaceuticals Inc?

Nicholas Simon is the 10 percent owner of Aerie Pharmaceuticals Inc. Other key executives at Aerie Pharmaceuticals Inc include Chief Financial Officer Peter Frederick Lang , director & Chief Executive Officer Raj Kannan , and Vice President of Finance Jeffrey Calabrese .

Aerie Pharmaceuticals Inc (AERI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerie Pharmaceuticals Inc (AERI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerie Pharmaceuticals Inc (AERI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerie Pharmaceuticals Inc (AERI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerie Pharmaceuticals Inc Insider Transactions

No Available Data

What does Globus Medical Inc do?

Who are the key executives at Globus Medical Inc?

Nicholas Simon is the other: Managing dir. of GP of Globus Medical Inc. Other key executives at Globus Medical Inc include director & Vice President & Operations David D Davidar , SVP & General Counsel Kelly Huller , and SVP & Chief Financial Officer Keith W Pfeil .

Globus Medical Inc (GMED) Insider Trades Summary

Over the past 18 months, Nicholas Simon made no insider transaction in Globus Medical Inc (GMED). Other recent insider transactions involving Globus Medical Inc (GMED) include a net sale of 106,750 shares made by Dan Lemaitre , a net sale of 29,167 shares made by Keith W Pfeil , and a net sale of 20,000 shares made by David D Davidar .

In summary, during the past 3 months, insiders sold 93,890 shares of Globus Medical Inc (GMED) in total and bought 0 shares, with a net sale of 93,890 shares. During the past 18 months, 174,007 shares of Globus Medical Inc (GMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 174,007 shares.

Globus Medical Inc (GMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

Globus Medical Inc Insider Transactions

No Available Data

What does Achillion Pharmaceuticals Inc do?

Who are the key executives at Achillion Pharmaceuticals Inc?

Nicholas Simon is the director of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , EVP & Chief Medical Officer Steven Zelenkofske , and General Counsel Martha E Manning .

Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achillion Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Nicholas Simon is the 10 percent owner of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zogenix Inc Insider Transactions

No Available Data

Nicholas Simon Mailing Address

Above is the net worth, insider trading, and ownership report for Nicholas Simon. You might contact Nicholas Simon via mailing address: 101 Main Street Suite 1210, Cambridge Ma 02142.

Discussions on Nicholas Simon

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.